| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $93.64K | $60.85K | $58.34K | $31.44K | $50.85K |
| R&D | – | – | – | – | – |
| SG&A | $15.34K | $8.08K | $7.64K | $10.68K | $20.42K |
| Operating Income | -$93.64K | -$60.85K | -$58.34K | -$31.44K | -$50.85K |
| Interest Expense | $9.85K | $8.35K | $7.44K | $6.34K | $5.35K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$93.64K | -$60.85K | -$50.44K | -$31.44K | -$50.85K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | -0.0200 | -0.0100 | -0.0100 | – | – |
| Shares (diluted) | $4.50M | $4.50M | $4.50M | – | – |